Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
PHASE3CompletedINTERVENTIONAL
Timeline
Start Date
January 31, 2004
Primary Completion Date
September 30, 2006
Study Completion Date
May 31, 2008
Conditions
Allergy
Interventions
BIOLOGICAL
Recombinant grass pollen
Trial Locations (1)
21465
Allergopharma GmbH & Co. KG, Reinbek
All Listed Sponsors
lead
Allergopharma GmbH & Co. KG
INDUSTRY
NCT00309036 - Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis | Biotech Hunter | Biotech Hunter